Granular biodurable nanomaterials: No convincing evidence for systemic toxicity

Area of Science:

• Toxicology
• Nanomaterial Safety
• Environmental Health

Background:

• Nanomaterials, defined as particles 1-100 nm, are increasingly studied for potential health impacts.
• Granular biodurable particles (GBP) without known specific toxicity, such as nanosized titanium dioxide and carbon black, are of particular interest.
• Concerns exist regarding the systemic accumulation and toxicity of these GBP nanomaterials.

Purpose of the Study:

• To evaluate experimental animal studies on the systemic levels and effects of GBP nanomaterials.
• To determine if GBP nanomaterials accumulate systemically and exhibit relevant toxicity.
• To compare the toxicological profiles of nanosized and microsized GBP materials.

Main Methods:

• Systematic review of 56 experimental animal studies on GBP nanomaterials.
• Analysis of studies investigating systemic absorption, distribution, and toxicological effects.
• Comparison of findings from studies using nanosized versus microsized GBP materials.

Main Results:

• Most reviewed studies (56 publications) did not adhere to standard OECD guidelines.
• Kinetic investigations revealed low absorption and systemic distribution of GBP nanomaterials.
• No evidence of novel toxicological hazards or specific systemic toxicity was identified for GBP nanomaterials.
• Studies comparing nano- and micro-sized GBP materials showed no significant differences in translocation or toxicity.

Conclusions:

• GBP nanomaterials exhibit limited systemic absorption and distribution in animal models.
• Current evidence does not indicate that GBP nanomaterials possess unique toxicological properties or significant systemic toxicity compared to their micro-sized counterparts.
• Further research using standardized protocols is warranted to fully elucidate the safety profile of GBP nanomaterials.